The earliest evidence of adaptive response to MEK inhibition in BC was reported almost a decade ago by independent groups[26,27], where they found inhibition of MEK led to unexpected and rapid activation of PI3K-AKT signalling. Here, MAP2K7 is linked to breast cancer.